Harvard Bioscience, Inc. (NASDAQ:HBIO) Q2 2023 Earnings Call Transcript August 8, 2023
Harvard Bioscience, Inc. misses on earnings expectations. Reported EPS is $0.04 EPS, expectations were $0.05.
Operator: Thank you for standing by and welcome to Harvard Bioscience’s Second Quarter 2023 Earnings Call. [Operator Instructions] I would now like to hand the call over to your host, David Sirois, Director of SEC Reporting. Please go ahead.
Dave Sirois: Thank you, Latif and good morning, everyone....
